- December 12, 2013 | BY
Eureka recently asked members of the Charles River scientific community what brewing scientific innovations and trends to look for in 2014. Here’s one example: Synthetic Biology.
- December 9, 2013 | BY
My low-carbohydrate epiphany occurred 11 years ago, when I discovered I had type 2 diabetes. As a physician, I should have known better. I had a strong family history of type 2 diabetes and I was working with the First Nations population (various Aboriginal peoples in Canada), where diabetes is rampant. Studies, such as ...
- December 2, 2013 | BY
A handheld tool that measures the properties making up bone has enabled researchers to validate a trend long associated with many diabetics—an increased risk of fractures.
- November 21, 2013 | BY
More than a year ago our technicians brought a problem to our attention–they were having to feed some cages almost daily instead of weekly.
- November 19, 2013 | BY
What mice can tell us about the connection between Alzheimer’s and immune function.
- November 15, 2013 | BY
For those who work in a vivarium it will come as no surprise that storage rooms could use a little less stimulation and a little more discipline.
- November 12, 2013 | BY
The Society for Neuroscience’s annual conference—the premier gathering for this very “cerebral” field—generally attracts an academic crowd.
- November 11, 2013 | BY
The ethics of animal research are not a black and white issue. Between the nothing goes and the anything goes there are at least 50 shades of grey.
- November 7, 2013 | BY
Charles River recently aided in a study involving wild rats who, let’s face it, represent a much different “clientele” than the well-bred laboratory rats we traditionally work with on a daily basis.
- November 4, 2013 | BY
It’s been 11 years since the US National Heart Lung and Blood Institute halted a major clinical trial1 testing the risks and benefits of estrogen plus progestin.